These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 17966175
1. Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. Lucky AW, Maloney JM, Roberts J, Taylor S, Jones T, Ling M, Garrett S, Dapsone Gel Long-Term Safety Study Group. J Drugs Dermatol; 2007 Oct; 6(10):981-7. PubMed ID: 17966175 [Abstract] [Full Text] [Related]
2. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, Garrett S, United States/Canada Dapsone Gel Study Group. J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334 [Abstract] [Full Text] [Related]
3. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris. Stotland M, Shalita AR, Kissling RF. Am J Clin Dermatol; 2009 Mar; 10(4):221-7. PubMed ID: 19489655 [Abstract] [Full Text] [Related]
8. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris. Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z. J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661 [Abstract] [Full Text] [Related]
9. A pilot study of the safety and efficacy of picolinic acid gel in the treatment of acne vulgaris. Heffernan MP, Nelson MM, Anadkat MJ. Br J Dermatol; 2007 Mar; 156(3):548-52. PubMed ID: 17300246 [Abstract] [Full Text] [Related]
10. Dapsone 7.5% Gel: A Review in Acne Vulgaris. Al-Salama ZT, Deeks ED. Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194 [Abstract] [Full Text] [Related]
12. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials. Eichenfield LF, Lain T, Frankel EH, Jones TM, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A. J Drugs Dermatol; 2016 Aug 01; 15(8):962-9. PubMed ID: 27537997 [Abstract] [Full Text] [Related]
13. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials. Stein Gold LF, Jarratt MT, Bucko AD, Grekin SK, Berlin JM, Bukhalo M, Weiss JS, Berk DR, Chang-Lin JE, Lin V, Kaoukhov A. J Drugs Dermatol; 2016 May 01; 15(5):553-61. PubMed ID: 27168264 [Abstract] [Full Text] [Related]